Semigran Marc's Form 4 filing
Edgewise Therapeutics, Inc. (EWTX) · filed Dec 27, 2024
- Accession no.
- 0001562180-24-008599
- Filed
- Dec 27, 2024
- Trade date
- Dec 24, 2024
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $881.9K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Semigran MarcCIK 0001691494 | Officer (Chief Development Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 24, 2024 | Common Stock | MOption exerciseAcquired | +29,709 | $8.94 | +$265,598.46 | 36,425 | Direct | |
| Dec 24, 2024 | Common Stock | SSaleDisposed | −27,980 | $29.66 | −$829,886.8 | 8,445 | Direct | |
| Dec 24, 2024 | Common Stock | SSaleDisposed | −1,729 | $30.08 | −$52,008.32 | 6,716 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 24, 2024 | Common Stock | MOption exerciseDisposed | −29,709 | $0.00 | $0 | 270,291 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.